Skip to content

Effect of Virechanakarma (Purgation therapy) in males having altered lipid levels in blood pertaining to Lingayat community

An open clinical trial to explore the effect of Virechanakarma on mRNA expression in dyslipidemic males of Belgaum district

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/10/004094
Enrollment
7
Registered
2013-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Deepana pachana with Hingwastaka churna, Snehapana with Panchatiktaguggulu ghrita, Sarvanga abhyanga with Triphaladya taila followed by Bhaspa sweda, Virechana with Trivrut lehya follow

Sponsors

IGIB New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients Age group between 30-50years From Belgaum district, specially lingayat community Kapha predominant prakruti persons (assessed based on questionnaire) 2 Diagnosed Dyslipidemia based on NCEP ATP III criteria

Exclusion criteria

Exclusion criteria: Virechana anahraâ??s Female patients Male patients having associated disorders like Diabetes Hypothyroidism Nephrotic syndrome Obstructive liver disease Chronic renal failure Drugs(that may raise LDLcholesterol or cause other dyslipidemia) â?? Progestins â?? Anabolic steroids â?? Corticosteroids â?? Protease inhibitors for treatment of HIV infections

Design outcomes

Primary

MeasureTime frame
Changes in mRNA expressionTimepoint: Changes in mRNA expression on day 1

Secondary

MeasureTime frame
Changes in mRNA expressionTimepoint: 12days

Countries

India

Contacts

Public ContactDrSuma SSJoshi

KLEUs Shri BMK Ayurveda Mahavidyalaya

sumamaski@gmail.com9449515046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026